QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, August 10, 2005, 25(32):7470-7479; doi:10.1523/JNEUROSCI.2120-05.2005

This Article Full Text Full Text (PDF) Supplemental data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Fortin, D. Articles by Bansal, R. Search for Related Content PubMed PubMed Citation Articles by Fortin, D. Articles by Bansal, R. Pubmed/NCBI databases Substance via MeSH

 Previous Article

Neurobiology of Disease
Distinct Fibroblast Growth Factor (FGF)/FGF Receptor Signaling Pairs Initiate Diverse Cellular Responses in the Oligodendrocyte Lineage

Dale Fortin,¹ Eran Rom,² Haijun Sun,³ Avner Yayon,² and Rashmi Bansal¹

¹Department of Neuroscience, University of Connecticut Medical School, Farmington, Connecticut 06030, ²ProChon Biotech Ltd., Rehovot, Israel 76114, and ³ImClone Systems Inc., New York, New York 10014

Fibroblast growth factors (FGFs) have been implicated in numerous cellular processes, including proliferation, migration, differentiation, and survival. Whereas FGF-2, the prototypic ligand in a family of 22 members, activates all four tyrosine kinase FGF receptors (FGFR1-FGFR4), other members demonstrate a higher degree of selectivity. Oligodendrocytes (OLs), the myelin-producing cells of the CNS, are highly influenced by FGF-2 at all stages of their development. However, how other FGFs and their cognate receptors orchestrate the development of OLs is essentially undefined. Using a combination of specific FGF ligands and receptor blocking antibodies, we now show that FGF-8 and FGF-17 target OL progenitors, inhibiting their terminal differentiation via the activation of FGFR3, whereas FGF-9 specifically targets differentiated OLs, triggering increases in process growth via FGFR2 signaling; FGF-18 targets both OL progenitors and OLs via activation of both FGFR2 and FGFR3. These events are highly correlated with changes in FGF receptor expression from FGFR3 to FGFR2 as OL progenitors differentiate into mature OLs. In addition, we demonstrate that, although activation of FGFR1 by FGF-2 leads to proliferation of OL progenitors, it produces deleterious effects on differentiated OLs (i.e., aberrant reentry into cell cycle and down-regulation of myelin proteins with a loss of myelin membrane). These data suggest that ligand availability, coupled with changes in FGF receptor expression, yield a changing repertoire of ligand-receptor signaling complexes that contribute critically to the regulation of both normal OL development and potential OL/myelin pathogenesis.

Key words: oligodendrocyte; myelin; FGF-2; FGF-8; FGF-9; fibroblast growth factor

---

Received April 20, 2005; accepted June 26, 2005.

This article has been cited by other articles:

				M. Furusho, J. L. Dupree, M. Bryant, and R. Bansal Disruption of Fibroblast Growth Factor Receptor Signaling in Nonmyelinating Schwann Cells Causes Sensory Axonal Neuropathy and Impairment of Thermal Pain Sensitivity J. Neurosci., February 11, 2009; 29(6): 1608 - 1614. [Abstract] [Full Text] [PDF]

				M. Dubois-Dalcq, A. Williams, C. Stadelmann, B. Stankoff, B. Zalc, and C. Lubetzki From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases Brain, July 1, 2008; 131(7): 1686 - 1700. [Abstract] [Full Text] [PDF]

				D. Maric, A. Fiorio Pla, Y. H. Chang, and J. L. Barker Self-Renewing and Differentiating Properties of Cortical Neural Stem Cells Are Selectively Regulated by Basic Fibroblast Growth Factor (FGF) Signaling via Specific FGF Receptors J. Neurosci., February 21, 2007; 27(8): 1836 - 1852. [Abstract] [Full Text] [PDF]

				M. Timmer, K. Cesnulevicius, C. Winkler, J. Kolb, E. Lipokatic-Takacs, J. Jungnickel, and C. Grothe Fibroblast Growth Factor (FGF)-2 and FGF Receptor 3 Are Required for the Development of the Substantia Nigra, and FGF-2 Plays a Crucial Role for the Rescue of Dopaminergic Neurons after 6-Hydroxydopamine Lesion J. Neurosci., January 17, 2007; 27(3): 459 - 471. [Abstract] [Full Text] [PDF]

				Y. Kaga, W. J. Shoemaker, M. Furusho, M. Bryant, J. Rosenbluth, S. E. Pfeiffer, L. Oh, M. Rasband, C. Lappe-Siefke, K. Yu, et al. Mice with Conditional Inactivation of Fibroblast Growth Factor Receptor-2 Signaling in Oligodendrocytes Have Normal Myelin But Display Dramatic Hyperactivity when Combined with Cnp1 Inactivation. J. Neurosci., November 22, 2006; 26(47): 12339 - 12350. [Abstract] [Full Text] [PDF]

				R. B. Fletcher, J. C. Baker, and R. M. Harland FGF8 spliceforms mediate early mesoderm and posterior neural tissue formation in Xenopus Development, May 1, 2006; 133(9): 1703 - 1714. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help